Literature DB >> 3760579

Three distinct H-2Ks molecules differing at the carboxy terminus are expressed on a tumor from SJL/J mice.

M J Rogers, D F Siwarski, E Shacter, W L Maloy, E P Lillehoj, J E Coligan.   

Abstract

A dimethylbenzanthracene-induced leukemia of H-2s origin expressed at least two class I molecules on the cell surface that were precipitated by anti-H-2.19, an alloantiserum prepared against the private H-2Ks specificity. Mapping studies in recombinant inbred strains along with comparisons of tryptic peptide maps and N-terminal sequences indicated that the proteins were virtually identical and probably encoded by the same class I gene. When cells were labeled in the presence of tunicamycin, the proteins precipitated by anti-H-2.19 were further resolved into three distinct peptides. Experiments were performed to determine which of these various proteins were phosphorylated and which were recognized by an anti-synthetic peptide serum directed against the ultimate C-terminus of H-2K class I molecules. The results indicate that a single class I gene from the H-2Ks region may encode three class I molecules that differ only at the C-terminus due to alternative splicing of pre-mRNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760579

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Class I major histocompatibility complex cDNA clones from sheep thymus: alternative splicing could make a long cytoplasmic tail.

Authors:  D Grossberger; W Hein; A Marcuz
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 2.  Multiple class I molecules generated from single genes by alternative splicing of pre-mRNAs.

Authors:  A M Lew; J McCluskey; W L Maloy; D H Margulies; J E Coligan
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 3.  Comparison of the primary structure of class I molecules.

Authors:  W L Maloy
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  A novel H-2K splice form: predictions for other alternative H-2 splicing events.

Authors:  J M Vogel; R Y Morse; R S Goodenow
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Three new class I HLA alleles: structure of mRNAs and alternative mechanisms of processing.

Authors:  L Cianetti; U Testa; L Scotto; R La Valle; A Simeone; G Boccoli; G Giannella; C Peschle; E Boncinelli
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Variations in the cytoplasmic region account for the heterogeneity of the chicken MHC class I (B-F) molecules.

Authors:  L B Møller; J Kaufman; S Verland; J Salomonsen; D Avila; J D Lambris; K Skjødt
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Activated T cells transcribe an alternatively spliced mRNA encoding a soluble form of Qa-2 antigen.

Authors:  N Ulker; K D Lewis; L E Hood; I Stroynowski
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

8.  The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications.

Authors:  R Linsk; S Watts; A Fischer; R S Goodenow
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.